Clinical Trial Update: Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating probiotics for minimal hepatic encephalopathy and health-related quality of life. The study was sponsored by CD …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• Liver Disease

Drugs mentioned

• Probiotic formulation

Snippet

Sponsor: CD Pharma India Pvt. Ltd. | Conditions: Chronic Liver Disease, Hepatic Encephalopathy | Phase 2, Phase 3 | Status: COMPLETED